413
Participants
Start Date
April 30, 2010
Primary Completion Date
September 30, 2014
Study Completion Date
November 30, 2018
Obinutuzumab
IV infusion.
Bendamustine
IV infusion.
Medizinische Universität Wien, Vienna
ZNA Stuivenberg, Antwerp
Inselspital Bern; Universitätsklinik für medizinische Onkologie, Bern
Universitaetsspital Basel; Onkologie, Basel
Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt., Salzburg
CHU Ambroise Paré, Mons
Kantonsspital Graubünden;Onkologie und Hämatologie, Chur
Lkh-Univ. Klinikum Graz, Graz
AZ Groeninge, Kortrijk
Azienda Ospedale San Giovanni, Turin
Ospedale Mauriziano Umberto I, Turin
Hematology Center; Karolinska Univ Hosp, Stockholm
Western Pennsylvania Hospital, Pittsburgh
Thomas Jefferson University Hospital, Philadelphia
Georgetown University Medical Center Lombardi Cancer Center, Washington D.C.
Asklepios Klinik St. Georg, Hamburg
Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milan
Washington DC VA Med Center; Hematology, Washington D.C.
CH Dijon, Dijon
Meritus Center for Clinical Research, Hagerstown
Skånes University Hospital, Skånes Department of Onclology, Lund
Irccs Policlinico San Matteo; Divisione Di Ematologia, Pavia
Hospital Universitario de la Princesa; Servicio de Hematologia, Madrid
Hospital Universitario La Paz, Madrid
Clinica Universitaria de Navarra, Pamplona
University of Florida, Gainesville
Md Anderson Cancer Center Orlando, Orlando
Institut Bergonie; Hematologie Oncologie, Bordeaux
Azienda Ospedaliera Univ, Ematologica, Udine
Polyclinique Bordeaux Nord, Bordeaux
CHU Bordeaux, Pessac
CHU Hopital Saint Eloi, Montpellier
Hopital Pontchaillou, Rennes
Southern Cancer Center, PC, Mobile
Univ Louisville School of Med, Louisville
Hospital Univ. Nuestra Señora de Valme;, Sevillac
Azienda Ospedaliera Universitaria di Modena, Modena
The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc., Columbus
Hopital Hotel Dieu Et Hme; Clinique Dermatologique, Nantes
St. Johannes Hospital Duisburg, Duisburg
Hospital Universitario Basurto, Bilbao
Azienda Ospedaliera Univ, Florence
CHU de Reims, Reims
University of Iowa, Iowa City
Univ of Wisconsin Hosp & Clin, Madison
CHRU de; Maladies, Vasculaires, Vandœuvre-lès-Nancy
Hopital Bon Secour, Metz
Sanford Health System, Sioux Falls
Hopital Claude Huriez, Lille
Rush Cancer Institute, Chicago
Quincy Medical Group, Quincy
Capitol Comprehensive CA Care, Jefferson City
Klinikum Frankfurt Höchst, Frankfurt am Main
Clinique Ste Anne, Strasbourg
Centre Leon Berard, Lyon
Centre Hospitalier Lyon Sud; Hematolgie, Pierre-Bénite
Centre d'oncologie-radiotherap, LeMans
Highlands Oncology Group, Rogers
Ospedale Vito Fazzi, Lecce
Hopital Necker, Paris
Hopital Saint Louis; Dermatologie 1, Paris
Centre Henri Becquerel, Rouen
University of Texas M.D. Anderson Cancer Center, Houston
Schwarzwald-Baar Klinikum GmbH, Villingen-Schwenningen
South Texas Inst of Cancer, Corpus Christi
Klinikum der Universitat Munchen, Campus Grobhadern;; Medizinische Klinik und Poliklinik III, München
Dr. Donald W. Hill, MD, FACP, Casa Grande
Chu De Poitiers; Chu La Miletrie, Poitiers
San Juan Oncology, Farmington
Kaiser Permanente - Bellflower, Bellflower
Sharp Memorial Hospital, San Diego
Hopital Henri Mondor, Créteil
Bay Area Cancer Research Group, LLC, Pleasant Hill
Azienda Ospedaliero Univ, Catania
OHSU Knight Cancer Institute, Portland
Pacific Oncology, PC, Portland
OHSU Ctr for Health & Healing, Portland
Fred Hutchinson Cancer Research Center, Seattle
Blokhin Cancer Research Center; Combined Treatment, Moscow
City Clin Hosp n.a. S.P.Botkin, Moscow
Russian Hema Res Ctr of RAMS, Moscow
Republican Clinical Hospital n.a. Baranov; Haematology, Petrozavodsk
SRI of Hematology and Transfusiology, Saint Petersburg
St. Petersburg State Medical University n.a. I.P. Pavlov; Hematology, transfusiology and transplanta, Saint Petersburg
Ryazan Regional Clinical Hosp, Ryazan
Regional Oncology Hospital, Irkutsk
University of Florida; Division of Hematology/Oncology, Gainesville
Simmons Cancer Institute, Springfield
New England Cancer Specialists, Scarborough
Hackensack University Medical Center, Hackensack
Hematology Oncology Assoc SJ, Mount Holly
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency, Kelowna
British Columbia Cancer Agency, Vancouver
Manitoba Cancer Care, Winnipeg
Moncton Hospital, Moncton
Toronto East General Hospital; Main Pharmacy G Wing Basement, East York
Princess Margaret Hospital, Toronto
CHUM-Hosp Notre Dame, Montreal
McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal
CHA Hopital de I enfant-Jesus, Québec
Allan Blair Cancer Centre, Regina
Fakultni nemocnice Brno; Interni hematologicka a onkologicka klinika, Brno
Fakultni nemocnice Hradec Kralove, Hradec Králové
I Interni klinika; Vseobecna fakultni nemocnice, Prague
Universitaetsklinikum Leipzig, Leipzig
Azienda Ospedaliera Univ, Rome
Universita La Sapienza, Rome
VU MEDISCH CENTRUM; Dept. of Medical Oncology, Amsterdam
Albert Schweitzer Ziekenhuis, Dordrecht
Universitair Medisch Centrum Groningen, Groningen
Erasmus Mc - Daniel Den Hoed Kliniek; Medical Oncology, Rotterdam
Erasmus MC, Rotterdam
Haga Ziekenhuis, The Hague
Norrlands Uni Hospital; Onkologi Avd., Umeå
Onc Clin, Akademiska Sjukhuset, Uppsala
Beatson West of Scotland Cancer Centre, Glasgow
Leicester Royal Infirmary, Leicester
Barts & London School of Med; Medical Oncology, London
Freeman Hospital, Newcastle upon Tyne
Singleton Hospital; Pharmacy Department, Swansea
Lead Sponsor
Roche Pharma AG
INDUSTRY
Genentech, Inc.
INDUSTRY